By PPN Staff
The FDA issued a communication regarding difficulties with critical safety alerts intended to be delivered via smartphone to various diabetes devices.
Affected devices include smartphone-compatible continuous glucose monitors, insulin pumps and automated insulin dosing systems. The corresponding smartphone apps allow users to configure alert settings, such as frequency of alerts and whether they are received by text, vibration or audibly. However, the FDA has received medical device